Publications

Cliquer sur l’article souhaité afin d’ouvrir le document

AYME S.

Dépistage de la trisomie 21 : où en sommes-nous ?

Médecine Science 1996 ; 12 : 393-396

SNIJDERS RJM, SUNDBERG K, HOLZGREVE W, HENRY G, NICOLAIDES KH.

Maternal age- and gestation-specific risk for trisomy 21.

Ultrasound Obstetric Gynecology 1999 ; 13 : 167-170

MORRIS JK, MUTTON DE, ALBERMAN E.

Revised estimates of the maternal age specific live birth prevalence of Down’s syndrome.

Journal Medical Screening 2002 ; 9 : 2-6

MULLER F, SAULT C, LEMAY C, ROUSSEL-MIZON N, FORESTIER F, FRENDO JL.

Second-trimester two-step trisomy 18 screening using maternal serum markers

Prenatal Diagnosis 2002 ; 22 : 605-608

MULLER F, FORESTIER F, DINGEON B, for ABA group.

Second-trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854902 patients.

Prenatal Diagnosis 2002 ; 22 : 925-929

MULLER F, THIBAUD D, POLOCE F, GELINEAU MC, BERNARD M, BROCHET C, MILLET C, REAL JY, DOMMERGUES M.

Risk of amniocentesis in women screened positive for Down syndrome with second-trimester maternal serum markers.

Prenatal Diagnosis 2002 ; 22 : 1036-1039

MULLER F, DREUX S, OURY JF, LUTON D, UZAN S, UZAN M, LEVARDON M, DOMMERGUES M.

Down syndrome maternal serum marker screening after 18 weeks’ gestation.

Prenatal Diagnosis 2002 ; 22 : 1001-1004

MULLER F, DREUX S, DUPOIZAT H, UZAN S, DUBIN MF, OURY JF, DINGEON B,

DOMMERGUES M.

Second-trimester Down syndrome maternal serum screening in twin pregnancies : Impact of chorionicity.

Prenatal Diagnosis 2003 ; 23 : 331-335

MULLER F, DREUX S, SAULT C, GALLAND A, PUISSANT H, COUPLET G, LEMAY C, LARCHER ME, RENOM G, ABA Group.

Very low alpha-fetoprotein in Down syndrome maternal serum screening.

Prenatal Diagnosis 2003 ; 23 : 584-587

MULLER F, BÉNATTAR C, AUDIBERT F, ROUSSEL N, DREUX S, H CUCKLE, for the French Collaborative Group.

First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers.

Prenatal Diagnosis 2003 ; 23 : 833-836

MULLER F, DREUX S, LEMEUR A, SAULT C, DESGRES J, BERNARD MA, GIORGETTI C, LEMAY C, MIRALLIE S, BEAUCHET A, for the French Collaborative Group.

Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.

Prenatal Diagnosis 2003 ; 23 : 1073-1076

GAUCHEZ AS, DREUX S, STEFANI L, MOUSSEAU M, JOUK PS, MULLER F.

Could ovarian choriocarcinoma be detected by maternal serum screening for Down syndrome ?

Prenatal Diagnosis 2007 ; 27 : 682-684

GARCHET-BEAUDRON A, DREUX S, LEPORRIER N, ABA Study Group, Clinical Study Group, OURY JF, MULLER F.

Second-trimester Down syndrome maternal serum marker screening : a prospective study of 11 040 twin pregnancies.

Prenatal Diagnosis 2008 ; 28 : 1105-1109

DREUX S, OLIVIER C, DUPONT JM, LEPORRIER N, Study Group, OURY JF, MULLER F.

Maternal serum screening in cases of mosaic and translocation Down syndrome.

Prenatal Diagnosis 2008 ; 28 : 699-703

GJERRIS AC, LOFT A, PINBORG A, CHRISTIANSEN M, TABOR A.

The effect of a ‘vanishing twin’ on biochemical and ultrasound first trimester screening markers for Down’s syndrome in pregnancies conceived by assisted reproductive technology.

Human Reproduction 2009 ; 24 : 55-62

SERMONDADE N, DREUX S, OURY JF, MULLER F.

Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome.

Prenatal Diagnosis 2009 ; 29 : 814-815

CUCKLE H.

Monitoring quality control of nuchal translucency.

Clinics Laboratory Medicine 2010 ; 30 : 593-604

BENACHI A, DREUX S, KADDIOUI-MAALEJ S, CZERKIEWICZ I, FAKHOURI F, THERVET E, MULLER F.

Down syndrome maternal serum screening in patients with renal disease.

Americna Journal Obstetrics Gynecology 2010 ; 203 : 60.e1-60.e4

HOURRIER S, SALOMON LJ, DREUX S, MULLER F.

Screening for adverse pregnancy outcome at early gestational age.

Clinica Chimica Acta 2010 ; 411 : 1547-1552

MULLER F, DREUX S, NGUYEN C, CZERKIEWICZ I.

Peut-on prévoir la fonction rénale postnatale en anténatal ?

Médecine Reproduction Gynécologie Endocrinologie 2010 ; 12 : 1-5

DREUX S, SALOMON LJ, MULLER F, GOFFINET F, OURY JF, ABA Study Group, SENTILHES L.

Second-trimester maternal serum markers and placenta accreta.

Prenatal Diagnosis 2012 ; 32 : 1010-1012

DREUX S, NGUYEN C, CZERKIEWICZ I, SCHMITZ T, AZRIA E, FOURE MA, MULLER F, ABA Study Group.

Down syndrome maternal serum marker screening after 18 weeks of gestation : a countrywide study.

American Journal Obstetrics Gynecology 2013 ; 397 : e1-e5

GIORGETTI C, VANDEN MEERSCHAUT F, DE ROO C, SAUNIER O, QUARELLO E, HAIRION D, PENARANDA G, CHABERT-ORSINI V, DE SUTTER P.

Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.

Human Reproduction 2013 ; 10 : 2636-2642

SPAGGIARI E, RUAS M, DREUX S, VALAT AS, CZERKIEWICZ I, GUIMIOT F, SCHMITZ T, DELEZOIDE AL, MULLER F.

Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay.

American Journal Obstetrics Gynecology 2013 ; 303 : e1-e7

GEBELLE R, ROGER C, DOCHE C, DOCHE L.

Dépistage de la trisomie 21 par les marqueurs sériques maternels au premier trimestre. Aspect pré-analytique.

Annales Biologie Clinique 2014 ; 2 : 207-212

MULLER F, DREUX S, CZERKIEWICZ I, BERNARD M, GUIBOURDENCHE J, LACROIX I, MOINEAU MP, READ MH, SAULT C, THIBAUD D, VEYRAT B, BIDAT L, ABA Study Group.

Dépistage de la trisomie 21 par les marqueurs sériques maternels : justification des commentaires appliqués par les biologistes.

Journal Gynécologie Obstétrique Biologie Reproduction 2014 ; 43 : 671-679

VALENTIN M, MULLER F, BEAUJARD MP, DREUX S, CZERKIEWICZ I, MEYER V, LERUEZ M, VILLE Y, SALOMON LJ.

First-trimester combined screening for trisomy 21 in women with renal disesase.

Prenatal Diagnosis 2015 ; 35 : 244-248

ROYERE D, on behalf of the working group trisomy 21 screening.

The impact of introducing combined first-trimester trisomy 21 screening in the Franch population.

European Journal of Public Health 2015 ; 1-6